The Leukemia Lymphoma Society S Therapy Acceleration

The Leukemia Lymphoma Society S Therapy Acceleration Program vs Nadeem Meghji

The Leukemia Lymphoma Society S Therapy Acceleration Program is a venture capital based in New York, New York, United States. Nadeem Meghji is a private equity based in New York across 709 portfolio companies. Sector focus diverges: The Leukemia Lymphoma Society S Therapy Acceleration Program concentrates on generalist deals and Nadeem Meghji on Proptech and Supply Chain Logistics.

• Investor type: The Leukemia Lymphoma Society S Therapy Acceleration Program — Venture Capital; Nadeem Meghji — Private Equity
• Headquarters: The Leukemia Lymphoma Society S Therapy Acceleration Program — New York, New York, United States; Nadeem Meghji — New York
• Portfolio companies: The Leukemia Lymphoma Society S Therapy Acceleration Program — not disclosed; Nadeem Meghji — 709
• Sectors: The Leukemia Lymphoma Society S Therapy Acceleration Program — not disclosed; Nadeem Meghji — Proptech, Supply Chain Logistics

• The Leukemia & Lymphoma Society’s Therapy Acceleration Program — Venture Capital · New York, New York, United States · The Leukemia Lymphoma Society S Therapy Acceleration Program portfolio
• Nadeem Meghji — Private Equity · New York · 709 tracked deals · Nadeem Meghji portfolio

Similar investors

• Steven G. Glenn
• Daniel Fabian
• Christopher Walsh
• Lexington Partners GP Holdings X, L.L.C.
• Antler Special Opportunities GP I LLC
• Thomas Teles
• Magnus Grimeland
• Tom Newby
• Pete Mathias
• Thomas S. Giannetti

Investors like The Leukemia Lymphoma Society S Therapy Acceleration Program · Investors like Nadeem Meghji · The Leukemia Lymphoma Society S Therapy Acceleration Program co-investors · Full investor directory